Regulation of Redox Homeostasis Through DNA/RNA Methylation and Post-Translational Modifications in Cancer Progression
Antioxidants & Redox Signaling · 01.09.2023 · 39 (7-9) · 531-550
DOI: 10.1089/ars.2023.0371 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, erschienen am 01.09.2023. Verfasst von Qiuchen Qi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: RNA, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 181 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, China.
- Shandong Provincial Key Laboratory of Laboratory Medicine Innovation Technology, Jinan, China.
- Shandong Engineering and Technology Research Center for Tumor Marker Detection, Jinan, China.
- Department of Clinical Laboratory, Qilu Hospital, Shandong University, Jinan, China.
ORCID-Profile: Qiuchen Qi
Zitieren
APA
Qi, Q., Yang, S., Li, J., Li, P., & Du, L. (2023). Regulation of Redox Homeostasis Through DNA/RNA Methylation and Post-Translational Modifications in Cancer Progression. Antioxidants & Redox Signaling, 39(7-9), 531-550. https://doi.org/10.1089/ars.2023.0371
Vancouver
Qi Q, Yang S, Li J, Li P, Du L. Regulation of Redox Homeostasis Through DNA/RNA Methylation and Post-Translational Modifications in Cancer Progression. Antioxidants & Redox Signaling. 2023;39(7-9):531-550. doi:10.1089/ars.2023.0371
BibTeX
@article{Qi2023,
author = {Qi, Qiuchen and Yang, Suli and Li, Juan and Li, Peilong and Du, Lutao},
title = {Regulation of Redox Homeostasis Through DNA/RNA Methylation and Post-Translational Modifications in Cancer Progression},
journal = {Antioxidants & Redox Signaling},
year = {2023},
volume = {39},
number = {7-9},
pages = {531--550},
doi = {10.1089/ars.2023.0371}
}
EUVIMED